These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 17976734)

  • 1. A more efficient enzyme-linked immunosorbent assay for measurement of alpha-synuclein in cerebrospinal fluid.
    van Geel WJ; Abdo WF; Melis R; Williams S; Bloem BR; Verbeek MM
    J Neurosci Methods; 2008 Feb; 168(1):182-5. PubMed ID: 17976734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid alpha-synuclein in neurodegenerative disorders-a marker of synapse loss?
    Ohrfelt A; Grognet P; Andreasen N; Wallin A; Vanmechelen E; Blennow K; Zetterberg H
    Neurosci Lett; 2009 Feb; 450(3):332-5. PubMed ID: 19022350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of alpha-synuclein concentration in human plasma using ELISA.
    Fjorback AW; Varming K; Jensen PH
    Scand J Clin Lab Invest; 2007; 67(4):431-5. PubMed ID: 17558898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of α-synuclein in cerebrospinal fluid as a biomarker candidate: review of the literature and considerations for future studies.
    Mollenhauer B; El-Agnaf OM; Marcus K; Trenkwalder C; Schlossmacher MG
    Biomark Med; 2010 Oct; 4(5):683-99. PubMed ID: 20945981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of electrochemiluminescence-based singleplex and multiplex assays for the quantification of α-synuclein and other proteins in cerebrospinal fluid.
    Kruse N; Schulz-Schaeffer WJ; Schlossmacher MG; Mollenhauer B
    Methods; 2012 Apr; 56(4):514-8. PubMed ID: 22465793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzyme-linked immunosorbent assay of total inhibin: direct determination based on inhibin alpha subunit-specific monoclonal antibodies.
    Khosravi J; Krishna RG; Khaja N; Bodani U; Diamandi A
    Clin Biochem; 2004 May; 37(5):370-6. PubMed ID: 15087252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of a commercially available enzyme-linked immunoabsorbent assay for the quantification of human α-Synuclein in cerebrospinal fluid.
    Kruse N; Mollenhauer B
    J Immunol Methods; 2015 Nov; 426():70-5. PubMed ID: 26271436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An enzyme immunoassay to quantify neurofilament light chain in cerebrospinal fluid.
    Van Geel WJ; Rosengren LE; Verbeek MM
    J Immunol Methods; 2005 Jan; 296(1-2):179-85. PubMed ID: 15680162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective detection, quantification, and subcellular location of alpha-synuclein aggregates with a protein aggregate filtration assay.
    Kramer ML; Behrens C; Schulz-Schaeffer WJ
    Biotechniques; 2008 Mar; 44(3):403-11. PubMed ID: 18361794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitive and specific detection of α-synuclein in human plasma.
    Tinsley RB; Kotschet K; Modesto D; Ng H; Wang Y; Nagley P; Shaw G; Horne MK
    J Neurosci Res; 2010 Sep; 88(12):2693-700. PubMed ID: 20648655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of a quantitative cerebrospinal fluid alpha-synuclein assay in a European-wide interlaboratory study.
    Kruse N; Persson S; Alcolea D; Bahl JM; Baldeiras I; Capello E; Chiasserini D; Bocchio Chiavetto L; Emersic A; Engelborghs S; Eren E; Fladby T; Frisoni G; García-Ayllón MS; Genc S; Gkatzima O; Heegaard NH; Janeiro AM; Kováčech B; Kuiperij HB; Leitão MJ; Lleó A; Martins M; Matos M; Mollergard HM; Nobili F; Öhrfelt A; Parnetti L; de Oliveira CR; Rot U; Sáez-Valero J; Struyfs H; Tanassi JT; Taylor P; Tsolaki M; Vanmechelen E; Verbeek MM; Zilka N; Blennow K; Zetterberg H; Mollenhauer B
    Neurobiol Aging; 2015 Sep; 36(9):2587-96. PubMed ID: 26093515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzyme-linked immunosorbent assays for α-synuclein with species and multimeric state specificities.
    Lee HJ; Bae EJ; Jang A; Ho DH; Cho ED; Suk JE; Yun YM; Lee SJ
    J Neurosci Methods; 2011 Aug; 199(2):249-57. PubMed ID: 21658411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of α-synuclein in cerebrospinal fluid: how ideal is this biomarker for Parkinson's disease?
    Mollenhauer B
    Parkinsonism Relat Disord; 2014 Jan; 20 Suppl 1():S76-9. PubMed ID: 24262194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AlphaLISA detection of alpha-synuclein in the cerebrospinal fluid and its potential application in Parkinson's disease diagnosis.
    Zhao H; Zhao J; Hou J; Wang S; Ding Y; Lu B; Wang J
    Protein Cell; 2017 Sep; 8(9):696-700. PubMed ID: 28555377
    [No Abstract]   [Full Text] [Related]  

  • 15. Detection of elevated levels of α-synuclein oligomers in CSF from patients with Parkinson disease.
    Bruggink KA; Kuiperij HB; Ekholm-Pettersson F; Verbeek MM
    Neurology; 2011 Aug; 77(5):510; author reply 510-1. PubMed ID: 21810701
    [No Abstract]   [Full Text] [Related]  

  • 16. Increase of the plasma α-synuclein levels in patients with multiple system atrophy.
    Sun ZF; Xiang XS; Chen Z; Zhang L; Tang BS; Xia K; Jiang H
    Mov Disord; 2014 Mar; 29(3):375-9. PubMed ID: 24115000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody-based methods for the measurement of α-synuclein concentration in human cerebrospinal fluid - method comparison and round robin study.
    Mollenhauer B; Bowman FD; Drake D; Duong J; Blennow K; El-Agnaf O; Shaw LM; Masucci J; Taylor P; Umek RM; Dunty JM; Smith CL; Stoops E; Vanderstichele H; Schmid AW; Moniatte M; Zhang J; Kruse N; Lashuel HA; Teunissen C; Schubert T; Dave KD; Hutten SJ; Zetterberg H
    J Neurochem; 2019 Apr; 149(1):126-138. PubMed ID: 30125936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Red blood cells are the major source of alpha-synuclein in blood.
    Barbour R; Kling K; Anderson JP; Banducci K; Cole T; Diep L; Fox M; Goldstein JM; Soriano F; Seubert P; Chilcote TJ
    Neurodegener Dis; 2008; 5(2):55-9. PubMed ID: 18182779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CSF alpha-synuclein levels in dementia with Lewy bodies and Alzheimer's disease.
    Noguchi-Shinohara M; Tokuda T; Yoshita M; Kasai T; Ono K; Nakagawa M; El-Agnaf OM; Yamada M
    Brain Res; 2009 Jan; 1251():1-6. PubMed ID: 19071095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and evaluation of an ELISA for quantification of human alpha-1-proteinase inhibitor in complex biological mixtures.
    Karnaukhova E; Golding B; Ophir Y
    Biologicals; 2007 Oct; 35(4):285-95. PubMed ID: 17257853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.